The Arginine-Nitric Oxide Pathway in Thrombotic Microangiopathy

Publisher Website
Google Scholar
Abstract
Eleven patients with thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) were investigated with respect to plasma concentrations of L-arginine, a substrate for nitric oxide (NO) and asymmetrical dimethyl arginine (ADMA), during active disease and after recovery. Plasma concentration of NO2, the degradation product of NO, was also analyzed. The patients were treated with fresh-frozed plasma and plasmapheresis. One of the patients had experienced relapses of TTP five times during the preceeding year. After treatment with p.0. arginine hydrochloride 1.5 g × 3 was started, no relapse has occurred during a 12-month period. During the active phase the plasma concentration of arginine was low and that of NO-3 was very high, indicating a high NO-synthesis rate. The arginine concentration normalized on recovery. Plasma levels of ADMA, was twice normal during active disease, and did not return to normal on recovery. In conclusion, patients with TTP/ HUS exhibit signs of activation of the NO-synthesis.